Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.
Vitamin D - immunomodulatory actions and new potentialities.
Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurol
Association Between MTHFR Genetic Variants and Multiple Sclerosis in a Southern Iranian Population.
Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.
Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial.
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS.
The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis.
Experiences of functional electrical stimulation (FES) and ankle foot orthoses (AFOs) for foot-drop in people with multiple sclerosis.
The role of diet in multiple sclerosis.
Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women.
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies.
How safe could intrathecal transplantation of mesenchymal stem cells be considered in multiple sclerosis?-Reply.
[Processing speed in relapsing-remitting multiple sclerosis: the role played by the depressive symptoms].
The history of neuromyelitis optica.
The Impact of a Patient Support Program for Multiple Sclerosis on Patient Satisfaction and Subjective Health Status.
Immunological differences between classical phenothypes of multiple sclerosis.
Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study.
PML risk stratification using anti-JCV antibody index and L-selectin.
GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions.
Frequency and economic impact of comorbid cardiac conditions with multiple sclerosis.
Genetic targeting of microglia.
Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume.
Pages
« first
‹ previous
…
255
256
257
258
259
260
261
262
263
…
next ›
last »